Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
HDA Dialogue Explores DE&I Efforts In the Distribution Sector
Discussions surrounding diversity, equity and inclusion (DE&I) are critically important to the healthcare distribution industry as this work ultimately strengthens the industry’s ability to deliver safe, affordable and efficient healthcare to patients across the nation. Earlier this month, HDA hosted a virtual discussion with four industry leaders who are fostering belonging within their organizations.
Building a More Climate Resilient Healthcare Supply Chain
Protecting the health of Americans begins with ensuring the well-being of our planet — and healthcare distributors recognize the industry’s responsibility to drive meaningful action on reducing climate change.
Prepare for 2023 DSCSA Compliance with HDA's Latest Industry Resources
In less than 18 months, the Drug Supply Chain Security Act (DSCSA) will reach its final milestone, culminating a 10-year implementation process across the healthcare supply chain. To help manufacturers and distributors prepare for interoperable data exchange, HDA, along with technical expertise from distributor- and manufacturer-member task force participants, has published new guidelines and other resources with the latest information and best practices.
Two Years To Go: All Hands Required To Meet DSCSA’s 2023 Deadline
The two-year countdown to the Drug Supply Chain Security Act (DSCSA) deadline has begun. This final milestone, in combination with those already completed, will fundamentally change how product and data move together across the healthcare supply chain.